title: Use of intravenous immunoglobulin prophylaxis for primary cytomegalovirus infection post living-related-donor renal transplantation.
authors.affiliation: Department of Hypertension, Cleveland Clinic Foundation, Ohio 44195-5042.
authors.forename: D R
authors.initials: DR
authors.lastname: Steinmuller
authors.forename: D
authors.initials: D
authors.lastname: Graneto
authors.forename: C
authors.initials: C
authors.lastname: Swift
authors.forename: A C
authors.initials: AC
authors.lastname: Novick
authors.forename: S B
authors.initials: SB
authors.lastname: Streem
authors.forename: R J
authors.initials: RJ
authors.lastname: Cunningham
authors.forename: E
authors.initials: E
authors.lastname: Hodge
authors.forename: P
authors.initials: P
authors.lastname: Bretan
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007167:Immunotherapy; D016030:Kidney Transplantation; D008297:Male; D012307:Risk Factors; D014019:Tissue Donors
chemical_list: D000961:Antilymphocyte Serum; D007136:Immunoglobulins